Meds Coupons

View Deals

8 Coupons

    • .. a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care. . .

    the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� .

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
    • .
    gallery
    .
  • .

    the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge. .